The evolution of treatment outcomes for resected stage IIIA non-small cell lung cancer over 16 years at a single institution

Journal of Thoracic and Cardiovascular Surgery

Volumn 130, Issue 6, 2005, Pages 1601-1610.e2

  Martin, Linda W ^a   Correa, Arlene M ^a   Hofstetter, Wayne ^a   Hong, Waun Ki ^a   Komaki, Ritsuko ^a   Putnam Jr , Joe B ^b   Rice, David C ^a   Smythe, W Roy ^c   Swisher, Stephen G ^a   Vaporciyan, Ara A ^a   Walsh, Garrett L ^a   Roth, Jack A ^a,d  

^a UNIVERSITY OF TEXAS   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c TEXAS A AND M UNIVERSITY   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLATINUM;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA BASE; FEMALE; FOLLOW UP; HUMAN; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PATHOLOGY; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 27944462626     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2005.08.010     Document Type: Article

References (31)

1. A. Jemal, T. Murray, E. Ward, A. Samuels, R.C. Tiwari, A. Ghafoor Cancer statistics, 2005 CA Cancer J Clin 55 2005 10 30
2. L.A. Robinson, H. Wagner Jr, J.C. Ruckdeschel American College of Chest Physicians Treatment of stage IIIA non-small cell lung cancer Chest. 123 suppl 2003 202S 220S
3. M.T. van Rens, A.B. de la Riviere, H.R. Elbers, J.M. Den Bosch Prognostic assessment of 2,361 patients who underwent pulmonary resection for non-small cell lung cancer, stage I, II, and IIIA Chest 117 2000 374 379
4. C.F. Mountain Revisions in the International System for Staging Lung Cancer Chest 111 1997 1710 1717
5. T. Naruke, K. Suemasu, S. Ishikawa Lymph node mapping and curability at various levels of metastasis in resected lung cancer J Thorac Cardiovasc Surg 76 1978 832 839
6. M. Inoue, N. Sawabata, S. Takeda, M. Ohta, Y. Ohno, H. Maeda Results of surgical intervention for p-stage IIIA (N2) non-small cell lung cancer: acceptable prognosis predicted by complete resection in patients with single N2 disease with primary tumor in the upper lobe J Thorac Cardiovasc Surg 127 2004 1100 1106
7. M. Okada, W. Nishio, T. Sakamoto, K. Uchino, T. Yuki, A. Nakagawa Evolution of surgical outcomes for nonsmall cell lung cancer: time trends in 1465 consecutive patients undergoing complete resection Ann Thorac Surg 77 2004 1926 1930
8. J. Martin, R.J. Ginsberg, A. Abolhoda, M.S. Bains, R.J. Downey, R. Korst Morbidity and mortality after neoadjuvant therapy for lung cancer: the risks of right pneumonectomy Ann Thorac Surg 72 2001 1149 1154
9. S.M. Keller, M.G. Vangel, H. Wagner, J.H. Schiller, A. Herskovic, R. Komaki Prolonged survival in patients with resected non-small cell lung cancer and single-level N2 disease J Thorac Cardiovasc Surg 128 2004 130 137
10. D.L. Miller, K.G. McManus, M.S. Allen, D.M. Ilstrup, C. Deschamps, V.F. Trastek Results of surgical resection in patients with N2 non-small cell lung cancer Ann Thorac Surg 57 1994 1095 1100
11. G.A. Patterson, D. Piazza, F.G. Pearson, T.R. Todd, R.J. Ginsberg, M. Goldberg Significance of metastatic disease in subaortic lymph nodes Ann Thorac Surg 43 1987 155 159
12. Y. Watanabe, J. Shimizu, M. Oda, Y. Hayashi, S. Watanabe, Y. Tatsuzawa Aggressive surgical intervention in N2 non-small cell cancer of the lung Ann Thorac Surg 51 1991 253 261
13. L.A. Aday, C.E. Begley, D.R. Lairson, R. Balkrishnan Effectiveness: concepts and methods. Evaluating the healthcare system: effectiveness, efficiency, and equity 2004 Health Administration Press Chicago, Ill p. 57-91
14. The Lung Cancer Study Group Effects of postoperative mediastinal radiation on completely resected stage II and stage III epidermoid cancer of the lung N Engl J Med. 315 1986 1377 1381
15. PORT Meta-analysis Trialists Group Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials Lancet. 352 1998 257 263
16. R. Mayer, F.M. Smolle-Juettner, D. Szolar, G.F. Stuecklschweiger, F. Quehenberger, G. Friehs Postoperative radiotherapy in radically resected non-small cell lung cancer Chest 112 1997 954 959
17. S.M. Keller, S. Adak, H. Wagner, A. Herskovic, R. Komaki, B.J. Brooks A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer Eastern Cooperative Oncology Group N Engl J Med 343 2000 1217 1222
18. R. Rosell, J. Gomez-Codina, C. Camps, J. Maestre, J. Padille, A. Canto A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer N Engl J Med 330 1994 153 158
19. R. Rosell, J. Gomez-Codina, C. Camps, J. Javier Sanchez, J. Maestre, J. Padilla Preresectional chemotherapy in stage IIIA non-small-cell lung cancer: a 7-year assessment of a randomized controlled trial Lung Cancer 26 1999 7 14
20. J.A. Roth, F. Fossella, R. Komaki, M.B. Ryan, J.B. Putnam Jr, J.S. Lee A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer J Natl Cancer Inst 86 1994 673 680
21. J.A. Roth, E.N. Atkinson, F. Fossella, R. Komaki, M. Bernadette Ryan, J.B. Putnam Jr Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer Lung Cancer 21 1998 1 6
22. K. Nagai, R. Tsuchiya, T. Mori, H. Tada, Y. Ichinose, T. Koike A randomized trial comparing induction chemotherapy followed by surgery with surgery alone for patients with stage IIIA N2 non-small cell lung cancer (JCOG 9209) J Thorac Cardiovasc Surg 125 2003 254 260
23. H.I. Pass, H.W. Pogrebniak, S.M. Steinberg, J. Mulshine, J. Minna Randomized trial of neoadjuvant therapy for lung cancer: interim analysis Ann Thorac Surg 53 1992 992 998
24. A. Depierre, B. Milleron, D. Moro-Sibilot, S. Chevret, E. Quoix, B. Lebeau Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small-cell lung cancer J Clin Oncol 20 2002 247 253
25. K.M. Pisters, R.J. Ginsberg, D.J. Giroux, J.B. Putnam Jr, M.G. Kris, D.H. Johnson Induction chemotherapy before surgery for early-stage lung cancer: a novel approach Bimodality Lung Oncology Team. J Thorac Cardiovasc Surg 119 2000 429 439
26. K.M. Pisters Combined modality therapy of early stage nonsmall cell lung cancer Respir Care Clin N Am 9 2003 191 205
27. Non-small Cell Lung Cancer Collaborative Group Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials BMJ. 311 1995 899 909
28. R. Arriagada, B. Bergman, A. Dunant, T. Le Chevalier, J.P. Pignon, J. Vansteenkiste Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer N Engl J Med 350 2004 351 360
29. G.V. Scagliotti, R. Fossati, V. Torri, L. Crino, G. Giaccone, G. Silvano Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell lung cancer J Natl Cancer Inst 95 2003 1453 1461
30. G.M. Strauss, J. Herndon, M.A. Maddaus, D.W. Johnstone, E.A. Johnson, D.M. Watson Randomized Clinical Trial of adjuvant chemotherapy with paclitaxel and carboplatin following resection in stage IB non-small cell lung cancer (NSCLC): report of Cancer and Leukemia Group B (CALGB) Protocol 9633 J Clin Oncol. 22 suppl 2004 7019
31. T.L. Winton, R. Livingston, D. Johnson, J. Rigas, Y. Cormier, C. Butts A prospective randomized trial of adjuvant vinorelbine (VIN) and cisplatin (CIS) in completely resected Stage IB and II non-small cell lung cancer (NSCLC) Intergroup JBR.10 J Clin Oncol. 22 2004 7018